LabVelocity operates in the biomedical research sector, providing high-quality antibodies and innovative laboratory methods validated through unbiased knockout studies. The company serves researchers, scientists, and academic institutions by offering a unique online journal, 'Materials and Methods,' which features regularly updated review articles on laboratory materials and methods. LabVelocity's business model revolves around curating and validating antibodies from formal publications, ensuring their reliability and effectiveness for research purposes. The company generates revenue through the sale of these validated antibodies and subscriptions to its online journal. By fostering effective communication between the biomedical research community and the reagent instrument industry, LabVelocity positions itself as a critical resource for advancing scientific discoveries.

Keywords: antibodies, knockout studies, biomedical research, laboratory methods, online journal, SARS CoV 2, reagent validation, research protocols, academic institutions, scientific discoveries.